FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220785887> ?p ?o ?g. }

• W4220785887 endingPage "1371" @default.
• W4220785887 startingPage "1356" @default.
• W4220785887 abstract "Osteoporotic vertebral fractures (OVF) dramatically increase with age and are serious life altering adverse events for seniors resulting in increased rates of institutionalization, morbidity and mortality. Given the expanding population of the elderly and increasing prevalence of OVFs, cost-effective treatment strategies need to be considered. Percutaneous vertebral augmentation (VA) procedures such as vertebroplasty (VP) or balloon kyphoplasty (BK) are increasingly employed to treat painful vertebral fractures not responding to conservative management (CM) of bedrest and analgesia. Both VA procedures have been shown to be effective treatments for OVFs in multiple systematic reviews of randomized controlled trials. In this systematic review, analytical strategies, designs and results were compared for health economic studies evaluating cost-effectiveness of VA procedures, VP or BK for OVFs. Furthermore, assessments of quality (risk of bias) were conducted for the systematic review and the individual studies with peer-reviewed checklists recommended for cost-effectiveness studies.To provide an up-to-date systematic review of peer-reviewed studies evaluating cost-effectiveness of VA procedures, VP or KP for OVFs to support treatment and health care funding decisions.This study is a systematic literature review and structured narrative synthesis.Peer reviewed health economic studies reporting cost-effectiveness for VA procedures, VP or BK for OVFs OUTCOME MEASURES: The following information extracted from the studies included: report country and year, study design, comparators, population, perspective, health valuations, costing sources and cost-effectiveness measures. For economic studies involving modeling, information was also extracted for model type, time horizon, key model drivers, and handling of uncertainty. Incremental cost-effectiveness ratio (ICER), the ratio of differences between comparator treatment groups in costs and health benefits, was considered the main cost-effectiveness measure.A systematic review was conducted of MEDLINE, EMBASE, CINAHL, ECONLIT, Cochrane Library and DARE databases up to the review date May 2021. Studies were reviewed for those reporting cost-effectiveness analyses on VA procedures including VP or BK for OVFs. Studies including only costs, abstracts, editorials, methodologies and reviews were not included. The selection of articles was reported in line with PRISMA guidance. A descriptive framework was developed to classify types of cost-effectiveness studies based on methodological differences and a structured narrative synthesis was used to summarize studies. Quality assessments were made with British Medical Journal checklist for individual cost-effectiveness studies and the CiCERO checklist for systematic reviews of cost-effectiveness studies.In this systematic review, 520 references were identified through database searching and 501 were excluded as ineligible by titles and abstract based on prior eligibility criteria. From full-text reviews of 19 reports, ten were identified as eligible for the systematic review evaluating cost-effectiveness of VA procedures for OVFs. All references were published between 2008 and 2020. The ten cost-effectiveness studies, three for VP, three for BK and four for both VP and BK, all involved CM for OVFs as a treatment comparator. The studies involved different methods of economic analysis, modeling assumptions, cost and health valuations conducted in different health care setting over different time periods. A framework for the review outlines key features of cost-effectiveness study designs consisting of unmatched, matched, or randomized controls involving cost-effectiveness or cost-utility) analyses. Both VP and BK were cost-effective alternatives to CM for OVFs with earlier health gains and significantly shorter hospital stays. Cost-effectiveness estimates, ICERs, remained relatively stable and within willingness-to-pay thresholds under a range of sensitivity analyses. Comparisons between VP and BK were variable depending on modeling assumptions, but generally the procedures had similar health benefit gains with VP having lower acute procedural costs.Both VP and BK, have been shown to be cost-effective alternatives to CM for osteoporotic vertebral fractures in diverse cost-effectiveness studies conducted in multiple health care settings. Trial-based cost-utility contributed the strongest evidence supporting cost-effectiveness determination for VP and BK for OVFs." @default.
• W4220785887 created "2022-04-03" @default.
• W4220785887 creator A5018193902 @default.
• W4220785887 creator A5024294949 @default.
• W4220785887 creator A5040907173 @default.
• W4220785887 creator A5042923287 @default.
• W4220785887 creator A5072071210 @default.
• W4220785887 date "2022-08-01" @default.
• W4220785887 modified "2023-10-05" @default.
• W4220785887 title "Cost-effectiveness studies of vertebral augmentation for osteoporotic vertebral fractures: a systematic review" @default.
• W4220785887 cites W1515702051 @default.
• W4220785887 cites W1593173821 @default.
• W4220785887 cites W1797693036 @default.
• W4220785887 cites W1974963363 @default.
• W4220785887 cites W1988980726 @default.
• W4220785887 cites W1989843302 @default.
• W4220785887 cites W1996968386 @default.
• W4220785887 cites W1998391182 @default.
• W4220785887 cites W2013098580 @default.
• W4220785887 cites W2018079465 @default.
• W4220785887 cites W2021782318 @default.
• W4220785887 cites W2031599047 @default.
• W4220785887 cites W2033329654 @default.
• W4220785887 cites W2034473215 @default.
• W4220785887 cites W2038364177 @default.
• W4220785887 cites W2041538343 @default.
• W4220785887 cites W2051890918 @default.
• W4220785887 cites W2052117311 @default.
• W4220785887 cites W2053796050 @default.
• W4220785887 cites W2059650971 @default.
• W4220785887 cites W2059724197 @default.
• W4220785887 cites W2060723964 @default.
• W4220785887 cites W2072473425 @default.
• W4220785887 cites W2075065709 @default.
• W4220785887 cites W2075523932 @default.
• W4220785887 cites W2082418053 @default.
• W4220785887 cites W2082810218 @default.
• W4220785887 cites W2083754422 @default.
• W4220785887 cites W2091876268 @default.
• W4220785887 cites W2094993869 @default.
• W4220785887 cites W2115133477 @default.
• W4220785887 cites W2115574045 @default.
• W4220785887 cites W2117419474 @default.
• W4220785887 cites W2118418653 @default.
• W4220785887 cites W2129511008 @default.
• W4220785887 cites W2144015558 @default.
• W4220785887 cites W2148849217 @default.
• W4220785887 cites W2158666395 @default.
• W4220785887 cites W2160353096 @default.
• W4220785887 cites W2161374186 @default.
• W4220785887 cites W2163466774 @default.
• W4220785887 cites W2169482413 @default.
• W4220785887 cites W2192894811 @default.
• W4220785887 cites W2282330348 @default.
• W4220785887 cites W2367412886 @default.
• W4220785887 cites W2615656344 @default.
• W4220785887 cites W2808024931 @default.
• W4220785887 cites W2808026070 @default.
• W4220785887 cites W2810488912 @default.
• W4220785887 cites W2883057410 @default.
• W4220785887 cites W2885978104 @default.
• W4220785887 cites W2895951036 @default.
• W4220785887 cites W2944120498 @default.
• W4220785887 cites W3020859100 @default.
• W4220785887 cites W3041413218 @default.
• W4220785887 cites W3153029604 @default.
• W4220785887 cites W4320288630 @default.
• W4220785887 cites W4385748211 @default.
• W4220785887 doi "https://doi.org/10.1016/j.spinee.2022.02.013" @default.
• W4220785887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35257838" @default.
• W4220785887 hasPublicationYear "2022" @default.
• W4220785887 type Work @default.
• W4220785887 citedByCount "3" @default.
• W4220785887 countsByYear W42207858872022 @default.
• W4220785887 countsByYear W42207858872023 @default.
• W4220785887 crossrefType "journal-article" @default.
• W4220785887 hasAuthorship W4220785887A5018193902 @default.
• W4220785887 hasAuthorship W4220785887A5024294949 @default.
• W4220785887 hasAuthorship W4220785887A5040907173 @default.
• W4220785887 hasAuthorship W4220785887A5042923287 @default.
• W4220785887 hasAuthorship W4220785887A5072071210 @default.
• W4220785887 hasBestOaLocation W42207858871 @default.
• W4220785887 hasConcept C112930515 @default.
• W4220785887 hasConcept C141071460 @default.
• W4220785887 hasConcept C142724271 @default.
• W4220785887 hasConcept C144133560 @default.
• W4220785887 hasConcept C160735492 @default.
• W4220785887 hasConcept C162324750 @default.
• W4220785887 hasConcept C162853370 @default.
• W4220785887 hasConcept C164624739 @default.
• W4220785887 hasConcept C168563851 @default.
• W4220785887 hasConcept C17744445 @default.
• W4220785887 hasConcept C177713679 @default.
• W4220785887 hasConcept C1862650 @default.
• W4220785887 hasConcept C189708586 @default.
• W4220785887 hasConcept C199539241 @default.
• W4220785887 hasConcept C2776125615 @default.
• W4220785887 hasConcept C2779473830 @default.

• next